Eastman Chemical Company — FY2022 Form 10-K
Reporting period: Fiscal year ended December 31, 2022. This is an annual report, not a standalone fourth-quarter results filing. Eastman is a global specialty materials company operating in Advanced Materials (AM), Additives & Functional Products (AFP), Chemical Intermediates (CI), and Fibers.
Financial performance
| Metric | 2022 | 2021 |
|---|---|---|
| Sales revenue | $10.580 billion | $10.476 billion |
| Gross profit / margin | $2.137 billion / 20.2% | $2.500 billion / 23.9% |
| EBIT / margin | $1.159 billion / 11.0% | $1.281 billion / 12.2% |
| Adjusted EBIT (non-GAAP) | $1.339 billion | $1.635 billion |
| Net earnings attributable to Eastman | $793 million | $857 million |
| Diluted EPS | $6.35 | $6.25 |
| Adjusted diluted EPS (non-GAAP) | $7.88 | $8.85 |
| Operating cash flow | $975 million | $1.619 billion |
| Capital expenditures | $611 million | $555 million |
Sales were nearly flat: price increases of 14% were largely offset by lower volume/product mix (3%), unfavorable currency effects (2%), and divestitures (8% contribution to the comparison). Management attributed weaker volumes to outages, divested businesses, softer demand, and customer inventory destocking, particularly in the fourth quarter. Adjusted EBIT fell 18%, reflecting lower volume, higher manufacturing costs and outages, and currency effects, partly offset by pricing and lower SG&A.
Segment results
| Segment | 2022 sales | 2022 EBIT | Change in EBIT vs. 2021 |
|---|---|---|---|
| Advanced Materials | $3.207 billion | $376 million | Down 28% |
| Additives & Functional Products | $3.165 billion | $483 million | Up 8% |
| Chemical Intermediates | $3.026 billion | $409 million | Down 8% |
| Fibers | $1.022 billion | $131 million | Down 8% |
AFP was the only segment with higher EBIT, aided by pricing and growth in care additives and animal nutrition. AM faced lower demand and outages; CI was pressured by lower volumes; and Fibers’ higher prices were offset by manufacturing costs. Segment results and comparisons reflect recasting of divested businesses into “Other.”
Liquidity, debt, and capital allocation
- Cash and cash equivalents were $493 million at year-end, versus $459 million in 2021. Current assets were $3.778 billion and current liabilities $3.251 billion.
- Total borrowings were $5.151 billion; management-defined net debt was $4.658 billion. Borrowings due within one year were $1.126 billion. The $1.50 billion revolving credit facility was undrawn, and the company reported covenant compliance.
- Operating cash flow declined by $644 million, primarily due to lower earnings and higher working-capital use, including inventory accumulation and variable compensation payments. Investing cash flow was positive $392 million, including $998 million of business-sale proceeds.
- Financing cash use was $1.321 billion, including $1.002 billion of treasury-stock purchases and $381 million of dividends paid. The company repurchased 10.7 million shares for $1.102 billion during 2022.
- 2023 capital spending was expected to be approximately $700 million to $800 million, mainly for growth projects and site modernization. A $0.79-per-share first-quarter 2023 dividend was declared.
Outlook, notable events, and risks
- No specific 2023 earnings or revenue guidance is stated in the supplied filing text. Management expects continued raw-material and energy cost volatility and plans to use pricing, hedging, and cost controls to mitigate it.
- The Kingsport steam-line failure on January 31, 2022 temporarily disrupted operations; affected areas were operational by March 31. Incident costs, net of insurance proceeds, were $39 million and excluded from adjusted EBIT.
- Eastman completed the adhesives resins divestiture in April 2022 for estimated consideration of $957 million. It recognized a $1 million loss on that transaction. The earlier rubber additives sale generated a cumulative reported loss of $594 million; $42 million was recognized in 2022. Divestiture-related losses and costs materially affected reported versus adjusted earnings.
- Management expected the Kingsport molecular-recycling plant to begin commissioning and startup by early summer 2023. The planned France facility was designed initially to process up to 110,000 metric tons annually; a third U.S. facility was also planned. Execution, feedstock supply, permits, costs, and commercial adoption remain important uncertainties.
- Key risks include economic slowdown and destocking, inflation and interest rates, raw-material and energy availability and prices, foreign-exchange movements, plant outages and safety incidents, global supply-chain disruption, cyclicality, environmental and climate regulation, and whether growth investments deliver expected returns.
- Environmental reserves were $274 million at year-end; estimated undiscounted remediation costs ranged from $245 million to $457 million. Management did not expect pending legal matters, including a tentative settlement of the Jefferson Hills environmental proceeding, to materially affect overall financial condition, results, or cash flows.
- The independent auditor gave an unqualified opinion on the financial statements and concluded internal control over financial reporting was effective. Goodwill impairment testing found reporting-unit fair values above carrying values, but the AFP goodwill assessment was identified as a critical audit matter.
Investor verification priorities
- Reconcile reported and adjusted earnings, including the $180 million of non-core and unusual EBIT items, and assess the recurring nature of adjustments.
- Track volume, pricing, customer destocking, and manufacturing utilization—especially whether conditions that weakened results in late 2022 persisted.
- Review operating cash conversion, inventory levels, receivables factoring, capital spending, and the effect of ongoing buybacks and dividends on liquidity.
- Assess debt maturities and exposure to variable rates, including the January 2023 $300 million term-loan draw and the $800 million notes due in 2023.
- Monitor delivery, funding, feedstock contracts, and expected returns for molecular-recycling and other growth projects.
- Review environmental remediation estimates, retained divestiture liabilities, and the eventual resolution of the Jefferson Hills proceeding.